Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
Neurotherapeutics
.
2021 Jul;18(3):2131.
doi: 10.1007/s13311-021-01062-1.
Authors
Elisabet Ampudia-Mesias
1
,
Francisco Puerta-Martinez
2
,
Miurel Bridges
3
,
David Zellmer
1
4
,
Andrew Janeiro
2
,
Matt Strokes
5
,
Yuk Y Sham
3
6
,
Ayman Taher
7
,
Maria G Castro
7
,
Christopher L Moertel
1
4
,
G Elizabeth Pluhar
4
8
,
Michael R Olin
9
10
11
Affiliations
1
Department of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA.
2
Department of Molecular and Computational Biology, University of Southern California, Los Angeles, CA, 90089, USA.
3
Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN, 55455, USA.
4
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.
5
Cell Signaling Technology, Inc, Danvers, MA, 09123, USA.
6
Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN, 55455, USA.
7
Department of Neurosurgery and Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
8
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.
9
Department of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA. olin0012@umn.edu.
10
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA. olin0012@umn.edu.
11
University of Minnesota, 2-167 Moos Tower, 515 Delaware St SE, Minneapolis, MN, 55455, USA. olin0012@umn.edu.
PMID:
33929711
PMCID:
PMC8608986
DOI:
10.1007/s13311-021-01062-1
No abstract available
Publication types
Published Erratum
Grants and funding
T32 DA007097/DA/NIDA NIH HHS/United States